Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting
Seminars in Liver Disease · 01.05.2023 · 43 (02) · 133-141
DOI: 10.1055/a-2082-5203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.05.2023. Verfasst von Esteban Urias und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDDK.
Abstract (Originalsprache)
While nonalcoholic fatty liver disease is a leading cause of end-stage liver disease, most patients with nonalcoholic fatty liver disease do not develop cirrhosis and its complications. Therefore, risk stratification using inexpensive, noninvasive screening modalities is critical to avoid overdiagnosis and overtreatment of a large proportion of the population. In this review, we discuss the data supporting screening and current professional society recommendations on this topic. Screening for at-risk nonalcoholic fatty liver disease is recommended in patients with risk factors including diabetes, the metabolic syndrome, hepatic steatosis, and elevated aminotransferases. Screening typically consists of noninvasive testing using serum biomarkers followed by elastography using specialized imaging modalities. This sequential screening approach accurately identifies both high- and low-risk patients and is cost-effective when applied to at-risk populations. In conclusion, screening for advanced nonalcoholic fatty liver disease in the primary care setting is a crucial part of identifying high-risk patients who may benefit from aggressive intervention while avoiding overtreatment of patients at low risk of liver-related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Förderung
- NIDDK NIH HHS
- NIDDK
Zitieren
APA
Urias, E., & Chen, V. L. (2023). Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting. Seminars in Liver Disease, 43(02), 133-141. https://doi.org/10.1055/a-2082-5203
Vancouver
Urias E, Chen VL. Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting. Seminars in Liver Disease. 2023;43(02):133-141. doi:10.1055/a-2082-5203
BibTeX
@article{Urias2023,
author = {Urias, Esteban and Chen, Vincent L},
title = {Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {02},
pages = {133--141},
doi = {10.1055/a-2082-5203}
}
EUVIMED